Fed’s Powell opens door to potential rate cuts at Jackson Hole
Tenet Healthcare Corp (NYSE:THC), a $15.1 billion healthcare provider with a GREAT financial health score according to InvestingPro, recently reported a significant stock transaction by Thomas W. Arnst, the company’s Executive Vice President, Chief Administrative Officer, and General Counsel. According to a filing with the Securities and Exchange Commission, Arnst sold 9,786 shares of Tenet Healthcare’s common stock on May 21, 2025. The shares were sold at a price of $166 each, amounting to a total transaction value of approximately $1.62 million.
Following this sale, Arnst holds no shares of Tenet Healthcare. The transaction was executed as a direct ownership sale.
In other recent news, Tenet Healthcare Corporation reported impressive financial results for the first quarter of 2025, with earnings per share (EPS) of $4.36, significantly surpassing the forecasted $3.17. The company achieved revenue of $5.22 billion, exceeding the anticipated $5.14 billion, driven by strong performance in its ambulatory surgery centers. Following these results, Tenet’s stock experienced a notable increase, reflecting investor confidence. Additionally, Tenet reaffirmed its full-year 2025 guidance, maintaining a positive outlook for future growth.
Analysts have also been adjusting their outlook on Tenet Healthcare. BofA Securities raised its price target for the company to $180, maintaining a Buy rating, citing the company’s strategic shift towards its Ambulatory Surgery Center business as a key growth driver. Meanwhile, Goldman Sachs increased its price target to $154 but maintained a Neutral rating, highlighting Tenet’s robust fundamentals and effective cost management in its Hospital segment. Cantor Fitzgerald reaffirmed an Overweight rating with a $177 price target, emphasizing the company’s appeal despite political uncertainties.
These recent developments underscore Tenet Healthcare’s strategic focus on expanding its ambulatory surgery centers and improving operational efficiency. The company continues to navigate the complex healthcare landscape, with a focus on strategic areas that promise growth and profitability. Investors are closely monitoring Tenet’s progress, particularly in its ASC business, which remains central to the company’s growth strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.